Abstract
In 1997 the FDA published a set of regulations for the pharmaceutical industry intended to establish controls over the use of computer technology. To briefly re-call this moment in history, the Electronic Records; Electronic Signature (ERES) regulation, 21CFR11 or Part 11, was introduced to provide criteria whereby electronic records (e.g., database information) would be considered ‘equivalent’ to paper records. The underlying motivation was a concern that technology could potentially invalidate the truth claim of an utterance (e.g., ‘this drug is effective’) by ‘scrambling’ the context of the utterance and by potentially falsifying the name (attributability) and the date (auditability). But this regulation was based on a premise, which I will argue, was founded on a metaphysical blind spot derived both from an underestimation of the difficulties inherent in the reconstitution of events (historiography), on the one hand, as well as an overestimation of the nefarious impact of technology, on the other. As a consequence, it is no surprise that the Part 11 narrative fell prey to an onto-theology of the worse kind, and as a consequence never uncovered the true essence of technology.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.